The 6th videoconference of the Scientific Group on Health Issues of the Turkic Council was held

The videoconference was held in order to follow the decisions made at the previous meetings and exchange experience of the Turkish side in the field of vaccine safety and the tracking system.

The meeting was moderated by Omer Kojaman, Deputy Secretary General of the Turkic Council, and was attended by Professor Dr. Emine Alp Meshe, Deputy Minister of Health of the Turkish Republic and Chairman of the Health Scientific Group, Dr. Victor Gasimov, Deputy Minister and the Chief Sanitary Doctor of the Republic of Azerbaijan, Mr. Nurbolot Usenbaev, Deputy Minister of Health of the Kyrgyz Republic, members of the Health Scientific Group and high-ranking officials from member and observer countries.

Deputy Secretary General Kojaman informed the participants about the activities carried out by the Secretariat and about the draft Action Plan for the implementation of the Memorandum of Understanding between the Turkic Council and the World Health Organization, signed between the two organizations on September 11, 2020.

Deputy Minister Alp Meshe provided information on the latest developments in vaccine research in Turkey and said that the 3rd phase of clinical trials of the local vaccine will begin in May. It was also mentioned that Turkey has already vaccinated more than 10 million people and will use its own vaccine in the first half of 2021.

The Deputy Minister also informed the participants that Turkey has started preparations for the training on "Infection Prevention and Control" in cooperation with the World Health Organization, which will be available to all Parties.

Dr Tarkan Mustafa Yamanoglu from the Public Health Directorate of the Turkish Ministry of Health made a presentation on the vaccine safety and traceability system. He highlighted Turkey's vaccine cold chain ability to maintain vaccine efficacy from production or storage to human injection and to ensure that a sufficient amount of effective vaccine reaches those in need.

After the presentation, the participants had a Q&A session related to the Covid-19 vaccination process, the effectiveness of the vaccine and its side effects, vaccination of people with chronic diseases and other problems of the pandemic.

The parties agreed to hold the next meeting of the Health Scientific Group based on the results of the current vaccination process, COVID-19 variants and mutations, and the effectiveness of the vaccine against new variants.